| Summary: | Rosario Gulias-Cañizo,1 Andres Benatti,2 Guillermo De Wit-Carter,3 Everardo Hernández-Quintela,3 Valeria Sánchez-Huerta3 1Universidad Anahuac Mexico, Huixquilucan, Estado de Mexico, Mexico; 2Cordoba Eye Clinic, Cornea and Refractive Surgery Department, Cordoba, Argentina; 3Asociación para Evitar la Ceguera en México, Hospital Dr. Luis Sanchez Bulnes, Cornea Department, Mexico City 04030, MexicoCorrespondence: Valeria Sánchez-HuertaAsociación para Evitar la Ceguera en México, Hospital Dr. Luis Sanchez Bulnes, Cornea Department, Vicente García Torres 46, San Lucas, Mexico City 04030, MexicoTel +5215525599999Fax +5215510841404Email valeriash@gmail.comPurpose: To investigate the efficacy of photoactivated chromophore corneal collagen cross-linking (PACK)-CXL in the management of treatment-resistant infectious keratitis.Design: Observational cohort study.Participants: Forty-two eyes from 41 patients with treatment-resistant infectious keratitis.Methods: Eyes underwent PACK-CXL treatment with the Dresden modified protocol in addition to standard antimicrobial therapy. The primary endpoint was the size of the corneal ulcer. Descriptive statistics, Wilcoxon rank test, McNemar test and Spearman correlation coefficient were used for statistical analysis, and p values lower than 0.05 were considered statistically significant.Results: Success rate at third postoperative month was of 90.5%. Statistical analyses showed a significant effect of (PACK)‑CXL with standard antimicrobial therapy to reduce corneal ulcer size (p=0.031).Conclusion: As adjuvant therapy to standard antimicrobial treatment, PACK-CXL improves the outcomes in patients with treatment-resistant corneal ulcers.Keywords: cross-linking, PACK-CXL, resistant keratitis
|
|---|
